ATP9A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.353600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.164600E-01
Normal-vs-Stage2
4.596400E-01
Normal-vs-Stage3
5.403400E-01
Normal-vs-Stage4
2.218000E-01
Stage1-vs-Stage2
3.668600E-01
Stage1-vs-Stage3
2.842500E-02
Stage1-vs-Stage4
7.256600E-01
Stage2-vs-Stage3
5.273600E-02
Stage2-vs-Stage4
2.514000E-01
Stage3-vs-Stage4
5.158300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.499000E-01
Normal-vs-AfricanAmerican
2.303800E-01
Normal-vs-Asian
6.494200E-01
Caucasian-vs-AfricanAmerican
6.316800E-01
Caucasian-vs-Asian
2.263000E-01
AfricanAmerican-vs-Asian
1.245190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.384000E-01
Normal-vs-Female
6.053400E-01
Male-vs-Female
9.132600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.267400E-01
Normal-vs-Age(41-60Yrs)
2.521200E-01
Normal-vs-Age(61-80Yrs)
6.467400E-01
Normal-vs-Age(81-100Yrs)
9.823800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.979600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.301600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.398500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.360230E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.784100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.000100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.753800E-01
Normal-vs-Daily Drinker
4.491000E-01
Normal-vs-Weekly Drinker
7.556800E-01
Normal-vs-Occasional Drinker
4.444800E-01
Normal-vs-Social Drinker
4.623400E-01
Non Drinker-vs-Daily Drinker
2.566000E-01
Non Drinker-vs-Weekly Drinker
9.733400E-01
Non Drinker-vs-Occasional Drinker
1.021200E-01
Non Drinker-vs-Social Drinker
2.045800E-01
Daily Drinker-vs-Weekly Drinker
2.992600E-01
Daily Drinker-vs-Occasional Drinker
1.987150E-01
Daily Drinker-vs-Social Drinker
5.224800E-01
Weekly Drinker-vs-Occasional Drinker
1.010830E-01
Weekly Drinker-vs-Social Drinker
2.024400E-01
Occasional Drinker-vs-Social Drinker
4.016800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.687200E-01
Normal-vs-Grade 2
6.189600E-02
Normal-vs-Grade 3
9.522500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.805600E-02
Grade 1-vs-Grade 3
2.078000E-01
Grade 1-vs-Grade 4
3.687200E-01
Grade 2-vs-Grade 3
2.097200E-01
Grade 2-vs-Grade 4
6.189600E-02
Grade 3-vs-Grade 4
9.522500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.036600E-01
Normal-vs-NonDiabetic
5.338800E-01
Diabetic-vs-NonDiabetic
6.856200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.438000E-01
Normal-vs-NoPancreatitis
5.873600E-01
Pancreatitis-vs-NoPancreatitis
7.402200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.622000E-01
Normal-vs-N1
4.695600E-01
N0-vs-N1
2.356000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.386600E-01
Normal-vs-TP53-NonMutant
4.740600E-01
TP53-Mutant-vs-TP53-NonMutant
2.610800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
